Nombre:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Fecha de publicación
2014-07-03
Metadatos
Mostrar el registro completo del ítemEditorial
Elsevier B.V.Journal
The LancetDOI
10.1016/S0140-6736(13)62087-5Enlaces adicionales
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2813%2962087-5/fulltextResumen
We read with interest the Lancet Series on Global Kidney Disease. Valerie Luyckx and colleagues describe the economics and medical management of chronic kidney disease in sub-Saharan Africa.1 We note clear similarities with patients in Peru. Indeed, in Peru, the Ministry of Health (MINSA)—which covers 70% of the population—does not have a comprehensive programme for the management of patients with chronic kidney disease, including renal replacement therapies. However, the Social Security System (Essalud)—which covers 20% of the population—has a chronic kidney disease programme.Tipo
info:eu-repo/semantics/articleDerechos
info:eu-repo/semantics/openAccessIdioma
engISSN
0140-6736EISSN
1474-547Xae974a485f413a2113503eed53cd6c53
10.1016/S0140-6736(13)62087-5
Scopus Count
Colecciones